111.51
price down icon0.11%   -0.12
after-market After Hours: 111.51
loading
Agilent Technologies Inc stock is traded at $111.51, with a volume of 1.72M. It is down -0.11% in the last 24 hours and down -11.37% over the past month. Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
See More
Previous Close:
$111.63
Open:
$113.17
24h Volume:
1.72M
Relative Volume:
0.78
Market Cap:
$31.51B
Revenue:
$7.07B
Net Income/Loss:
$1.29B
P/E Ratio:
24.59
EPS:
4.5355
Net Cash Flow:
$993.00M
1W Performance:
-3.09%
1M Performance:
-11.37%
6M Performance:
-9.52%
1Y Performance:
-4.96%
1-Day Range:
Value
$111.02
$113.65
1-Week Range:
Value
$110.89
$117.03
52-Week Range:
Value
$96.43
$160.27

Agilent Technologies Inc Stock (A) Company Profile

Name
Name
Agilent Technologies Inc
Name
Phone
(408) 345-8886
Name
Address
5301 STEVENS CREEK BLVD, SANTA CLARA, CA
Name
Employee
18,100
Name
Twitter
@agilent
Name
Next Earnings Date
2026-02-25
Name
Latest SEC Filings
Name
A's Discussions on Twitter

Compare A vs TMO, DHR, IDXX, WAT

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
A
Agilent Technologies Inc
111.51 31.51B 7.07B 1.29B 993.00M 4.5355
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
464.37 172.51B 44.56B 6.72B 6.29B 17.74
Diagnostics & Research icon
DHR
Danaher Corp
187.32 132.46B 24.57B 3.60B 5.26B 5.051
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
573.82 45.69B 4.30B 1.06B 1.04B 13.08
Diagnostics & Research icon
WAT
Waters Corp
286.57 28.11B 3.17B 642.63M 516.49M 10.77

Agilent Technologies Inc Stock (A) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-20-26 Initiated HSBC Securities Buy
Jan-05-26 Upgrade Evercore ISI In-line → Outperform
Dec-15-25 Upgrade Barclays Equal Weight → Overweight
Dec-09-25 Initiated Goldman Buy
Dec-02-25 Initiated Morgan Stanley Overweight
Oct-08-25 Initiated Rothschild & Co Redburn Buy
Oct-08-25 Upgrade UBS Neutral → Buy
Feb-10-25 Upgrade Barclays Underweight → Equal Weight
Aug-28-24 Initiated Wells Fargo Overweight
Jul-10-24 Upgrade Citigroup Neutral → Buy
Jun-27-24 Downgrade Wolfe Research Outperform → Peer Perform
Jun-03-24 Resumed Jefferies Hold
Apr-05-24 Upgrade Stifel Hold → Buy
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Downgrade BofA Securities Buy → Neutral
Nov-17-23 Downgrade UBS Buy → Neutral
Sep-28-23 Initiated Bernstein Mkt Perform
Jul-31-23 Downgrade Evercore ISI Outperform → In-line
May-24-23 Reiterated Barclays Equal Weight
May-24-23 Reiterated BofA Securities Buy
May-24-23 Reiterated Citigroup Neutral
May-24-23 Reiterated Credit Suisse Outperform
May-24-23 Reiterated Evercore ISI Outperform
May-24-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
May-24-23 Reiterated Robert W. Baird Outperform
May-24-23 Reiterated SVB Securities Outperform
May-24-23 Reiterated Stifel Hold
May-24-23 Reiterated TD Cowen Outperform
May-24-23 Reiterated Wells Fargo Overweight
May-11-23 Initiated Barclays Equal Weight
Jan-10-23 Upgrade Wells Fargo Equal Weight → Overweight
Aug-25-22 Initiated Credit Suisse Outperform
Jul-20-22 Initiated UBS Buy
Jul-08-22 Downgrade Citigroup Buy → Neutral
Apr-25-22 Downgrade Wells Fargo Overweight → Equal Weight
Feb-23-22 Reiterated BofA Securities Buy
Feb-23-22 Reiterated Citigroup Buy
Feb-23-22 Reiterated Cowen Outperform
Feb-23-22 Reiterated Evercore ISI Outperform
Feb-23-22 Reiterated Stifel Hold
Feb-23-22 Reiterated Wells Fargo Overweight
Nov-23-21 Reiterated BofA Securities Buy
Nov-23-21 Reiterated Cowen Outperform
Nov-23-21 Reiterated Stifel Hold
Mar-18-21 Upgrade Citigroup Neutral → Buy
Feb-17-21 Upgrade BofA Securities Neutral → Buy
Dec-02-20 Initiated Goldman Buy
Nov-25-20 Upgrade UBS Neutral → Buy
Nov-17-20 Upgrade Cleveland Research Neutral → Buy
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Sep-30-20 Initiated Atlantic Equities Neutral
Aug-19-20 Reiterated BofA Securities Neutral
Aug-19-20 Reiterated Citigroup Neutral
Aug-19-20 Reiterated Jefferies Buy
Aug-19-20 Reiterated Robert W. Baird Outperform
Aug-19-20 Reiterated SVB Leerink Outperform
Aug-19-20 Reiterated Stifel Hold
Aug-19-20 Reiterated Wells Fargo Overweight
Feb-24-20 Downgrade Needham Buy → Hold
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Neutral
Nov-26-19 Reiterated Needham Buy
Nov-15-19 Initiated Stifel Hold
Oct-18-19 Downgrade UBS Buy → Neutral
Jul-16-19 Downgrade BofA/Merrill Buy → Neutral
Jul-15-19 Downgrade Barclays Overweight → Equal Weight
View All

Agilent Technologies Inc Stock (A) Latest News

pulisher
08:09 AM

Wellington Management Group LLP Purchases 433,342 Shares of Agilent Technologies, Inc. $A - MarketBeat

08:09 AM
pulisher
04:50 AM

Integral Health Asset Management LLC Boosts Position in Agilent Technologies, Inc. $A - MarketBeat

04:50 AM
pulisher
Mar 13, 2026

Deal Dispatch: Papa John's May Go Private, Shell Buys Jiffy Lube, Meta Acquires Moltbook - Benzinga

Mar 13, 2026
pulisher
Mar 13, 2026

Magnetar Financial LLC Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Schroder Investment Management Group Buys 75,796 Shares of Agilent Technologies, Inc. $A - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Agilent Technologies, Inc. $A Shares Purchased by Natixis Advisors LLC - MarketBeat

Mar 13, 2026
pulisher
Mar 13, 2026

Preventive Control Of Sequencing Through The Insert With The Agilent 5200 Fragment Analyzer System - Bioprocess Online

Mar 13, 2026
pulisher
Mar 12, 2026

Agilent Expands CDMO Role With Advanced Therapeutics As Shares Lag Targets - simplywall.st

Mar 12, 2026
pulisher
Mar 12, 2026

Agilent Technologies Inc (A) Trading Down 3.59% on Mar 12 - GuruFocus

Mar 12, 2026
pulisher
Mar 12, 2026

Agilent Technologies, Inc. (A) price target cut to $155 at Baird - MSN

Mar 12, 2026
pulisher
Mar 12, 2026

Vestcor Inc Sells 10,204 Shares of Agilent Technologies, Inc. $A - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Mackenzie Financial Corp Buys 324,461 Shares of Agilent Technologies, Inc. $A - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Agilent unifies CDMO capabilities across Canada and United States - BioSpectrum India

Mar 12, 2026
pulisher
Mar 12, 2026

Legal & General Group Plc Raises Position in Agilent Technologies, Inc. $A - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Korea Investment CORP Has $12.95 Million Stake in Agilent Technologies, Inc. $A - MarketBeat

Mar 12, 2026
pulisher
Mar 12, 2026

Agilent launches unified CDMO business combining US, Canada units - Investing.com India

Mar 12, 2026
pulisher
Mar 12, 2026

Blair William & Co. IL Decreases Holdings in Agilent Technologies, Inc. $A - MarketBeat

Mar 12, 2026
pulisher
Mar 11, 2026

Lab chromatographs are quietly getting an AI upgrade in the US - AD HOC NEWS

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent Launches Advanced Therapeutics CDMO Solution for US and Canada - Contract Pharma

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent’s Biocare Deal Reshapes Pathology Presence As Shares Lag Targets - simplywall.st

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent Launches Agilent Advanced Therapeutics, Unifying CDMO Capabilities Across Canada and United States - BioSpace

Mar 11, 2026
pulisher
Mar 11, 2026

Citi Flags Agilent Technologies, Cuts Icon PLC Target, and More - AOL.com

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent Technologies, Inc. $A Shares Sold by Swiss National Bank - MarketBeat

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent launches unified CDMO division across Canada and United States - StreetInsider

Mar 11, 2026
pulisher
Mar 11, 2026

Lab Chromatographs Are Quietly Getting Smarter. Here Is Why It Matters - AD HOC NEWS

Mar 11, 2026
pulisher
Mar 11, 2026

Jim Cramer on Agilent Technologies: “I Don’t Think You Need It” - Yahoo Finance

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent (A) Gains Positive Outlook with Analyst's 90-Day Catalys - GuruFocus

Mar 11, 2026
pulisher
Mar 11, 2026

Agilent Technologies, Inc. $A Shares Sold by Russell Investments Group Ltd. - MarketBeat

Mar 11, 2026
pulisher
Mar 10, 2026

Agilent Bets On Pathology Innovation With Biocare Acquisition - Yahoo Finance

Mar 10, 2026
pulisher
Mar 10, 2026

Agilent Technologies announces planned retirement of principal accounting officer - Investing.com Nigeria

Mar 10, 2026
pulisher
Mar 10, 2026

Agilent snaps up pathology firm Biocare Medical for $950 million - malaysiasun.com

Mar 10, 2026
pulisher
Mar 10, 2026

Is Agilent Technologies Stock Underperforming the S&P 500? - Barchart

Mar 10, 2026
pulisher
Mar 10, 2026

Comprehensive Insights into Antibody–Drug Conjugates (ADC) for Precision Cancer Therapy - CHEManager

Mar 10, 2026
pulisher
Mar 10, 2026

Van ECK Associates Corp Sells 10,815 Shares of Agilent Technologies, Inc. $A - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Ceredex Value Advisors LLC Makes New $24.39 Million Investment in Agilent Technologies, Inc. $A - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Why Agilent Technologies Just Paid $950 Million For Biocare Medical (NYSE:A) - Seeking Alpha

Mar 10, 2026
pulisher
Mar 10, 2026

First Trust Advisors LP Increases Stock Position in Agilent Technologies, Inc. $A - MarketBeat

Mar 10, 2026
pulisher
Mar 10, 2026

Bank of America Maintains Neutral on Agilent Technologies (A) March 2026 - Meyka

Mar 10, 2026
pulisher
Mar 10, 2026

Agilent to buy Biocare Medical from Excellere and GHO Capital - pehub.com

Mar 10, 2026
pulisher
Mar 09, 2026

Agilent Technologies: $950 Million Acquisition Of Pathology Diagnostics Company Biocare Medical - Pulse 2.0

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent Technologies to acquire Biocare Medical for $950 million - The American Bazaar

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent Technologies Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent Technologies to Acquire Biocare Medical in $950 Million Deal - Clinical Lab Products

Mar 09, 2026
pulisher
Mar 09, 2026

Why Agilent Stock Is Slipping Premarket Today - Stocktwits

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent to Acquire Biocare Medical in $950 Million All-Cash Deal - TradingView

Mar 09, 2026
pulisher
Mar 09, 2026

Sullivan & Cromwell Advises Agilent On $950M Biocare Buy - Law360

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent to buy Biocare Medical for $950M - Healthcare Dive

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent Technologies to acquire Biocare Medical in $950m deal - Medical Device Network

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent TechnologiesConsidering Adding Here, As It Adds To Its Portfolio (NYSE:A) - Seeking Alpha

Mar 09, 2026
pulisher
Mar 09, 2026

Agilent buys Biocare for $950M - BioWorld MedTech

Mar 09, 2026
pulisher
Mar 09, 2026

BofA reiterates Agilent stock rating on Biocare acquisition - Investing.com

Mar 09, 2026

Agilent Technologies Inc Stock (A) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research WAT
$286.57
price up icon 1.15%
diagnostics_research IQV
$164.72
price up icon 1.10%
$187.85
price down icon 1.29%
diagnostics_research MTD
$1,173.74
price up icon 0.49%
diagnostics_research DGX
$199.70
price down icon 0.59%
Cap:     |  Volume (24h):